Corrigendum to "Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose" [Diabetes Res. Clin. Pract. 75 (2006) 207-213] (DOI:10.1016/j.diabres.2006.06.003);Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 207-213

  Quadros, Alexandre S ^a   Sarmento Leite, Rogério ^a   Bertoluci, Marcello ^b   Duro, Kauê ^a   Schmidt, Alexandre ^b   De Lucca Jr , Giuseppe ^a   Schaan, Beatriz D ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Coronary artery disease; Glucose metabolism; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE;

EID: 33845388554     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.014     Document Type: Erratum

References (34)

1. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
2. Mokdad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F., et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23 (2000) 1278-1283
3. Schaan B., Harzheim E., and Gus I. [Cardiac risk profile in diabetes mellitus and impaired fasting glucose]. Rev Saude Publica 38 (2004) 529-536
4. Hanefeld M., Koehler C., Schaper F., Fuecker K., Henkel E., and Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144 (1999) 229-235
5. Glucose Tolerance and Mortality: Comparison of WHO and American Diabetes Association Diagnostic Criteria, The DECODE Study Group, European Diabetes Epidemiology Group, Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe, Lancet 354 (1999) 617-621.
6. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
7. Haffner S.M., Mykkanen L., Festa A., Burke J.P., and Stern M.P. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101 (2000) 975-980
8. Gerstein H.C., Anand S., Yi Q.L., Vuksan V., Lonn E., Teo K., et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 26 (2003) 144-149
9. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
10. Balkau B., Jarrett R.J., Pyorala K., and Eschwege E. Fasting blood glucose and risk of cardiovascular disease. Diabetes Care 22 (1999) 1385-1387
11. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
12. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322 (2001) 15-18
13. Kowalska I., Prokop J., Bachorzewska-Gajewska H., Telejko B., Kinalskal I., Kochman W., et al. Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis. Diabetes Care 24 (2001) 897-901
14. Natali A., Vichi S., Landi P., Severi S., L'Abbate A., and Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 43 (2000) 632-641
15. Freedman D.S., Gruchow H.W., Bamrah V.S., Anderson A.J., and Barboriak J.J. Diabetes mellitus and arteriographically-documented coronary artery disease. J. Clin. Epidemiol. 41 (1988) 659-668
16. Piché M.E., Arcand-Bosse J.F., Despres J.P., Perusse L., Lemieux S., and Weisnagel S.J. What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care 27 (2004) 2470-2477
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
18. Law M.R., and Wald N.J. Risk factor thresholds: their existence under scrutiny. BMJ 324 (2002) 1570-1576
19. Scheidt-Nave C., Barrett-Connor E., Wingard D.L., Cohn B.A., and Edelstein S.L. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am. J. Epidemiol. 133 (1991) 565-576
20. Bjornholt J.V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22 (1999) 45-49
21. Ferranini E., Vichi S., Natali A., and Severi S. Cardiac disease in diabetic patients. J. Cardiovasc. Pharmacol. 28 4 (1996) S16-S22
22. Tuttle K.R., Puhlman M.E., Cooney S.K., and Short R. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am. J. Kidney Dis. 34 (1999) 918-925
23. Solymoss B.C., Bourassa M.G., Campeau L., Sniderman A., Marcil M., Lesperance J., et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am. J. Cardiol. 93 (2004) 159-164
24. Sasso F.C., Carbonara O., Nasti R., Campana B., Marfella R., Torella M., et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA 291 (2004) 1857-1863
25. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 12 (1988) 56-62
26. Fuster V., Stein B., Ambrose J.A., Badimon L., Badimon J.J., and Chesebro J.H. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82 (1990) II47-II59
27. Little W.C. Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction. Am. J. Cardiol. 66 (1990) 44G-47G
28. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316 (1987) 1371-1375
29. Schoenhagen P., Tuzcu E.M., and Ellis S.G. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. Circulation 106 (2002) 760-762
30. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 (2002) 1557-1565
31. Folsom A.R., Pankow J.S., Tracy R.P., Arnett D.K., Peacock J.M., Hong Y., et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am. J. Cardiol. 88 (2001) 112-117
32. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310 (1984) 356-360
33. Zelmanovitz T., Gross J.L., Oliveira J.R., Paggi A., Tatsch M., and Azevedo M.J. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20 (1997) 516-519
34. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176